Oct 05, 2023
From 12 PM to 1 PM
Illuminating Drug Development's AI Frontier
Join us on Thursday, October 5th at 12 pm ET for a captivating and insightful session as we welcome Dr. Yoshua Bengio, a trailblazer in the field of artificial intelligence, for the next adMare Global Leader Series.
This exclusive event offers a unique opportunity to gain deep insights into the intersection of AI and life sciences, focusing on the evolution of drug development. Drawing from his extensive expertise, Dr. Bengio will explore the current advancements, challenges, and the immense potential AI holds for accelerating drug discovery and enhancing patient outcomes.
About Dr. Bengio
Recognized worldwide as one of the leading experts in artificial intelligence, Yoshua Bengio is most known for his pioneering work in deep learning, earning him the 2018 A.M. Turing Award, “the Nobel Prize of Computing,” with Geoffrey Hinton and Yann LeCun.
He is Full Professor at Université de Montréal, and the Founder and Scientific Director of Mila – Quebec AI Institute. He co-directs the CIFAR Learning in Machines & Brains program as Senior Fellow and acts as Scientific Director of IVADO.
In 2019, he was awarded the prestigious Killam Prize and in 2022, became the most cited computer scientist in the world. He is a Fellow of both the Royal Society of London and Canada, Knight of the Legion of Honor of France, Officer of the Order of Canada, and a Canada CIFAR AI Chair.
He is deeply concerned about how AI impacts society and has actively contributed to efforts such as the Montreal Declaration for Responsible Development of Artificial Intelligence (2017) and the UNESCO-Mila book 'Missing Links in AI Governance' (2023). In addition, he is a co-signatory of the FLI letter and CAIS AI risk statement in 2023. Recently, Yoshua Bengio was appointed as a member of the UN's secretary general's Scientific Advisory Board for Independent Advice on Breakthroughs in Science and Technology, as well as an external member of the UK's Frontier AI Taskforce regarding the risks and opportunities associated with AI.